Amalgamated Bank’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,566
Closed -$41K 2836
2025
Q4
$41K Sell
1,566
-314
-17% -$6.85K ﹤0.01% 1878
2025
Q3
$32K Hold
1,880
﹤0.01% 1975
2025
Q2
$24K Hold
1,880
﹤0.01% 2049
2025
Q1
$22K Buy
1,880
+81
+5% +$1.1K ﹤0.01% 2036
2024
Q4
$26K Hold
1,799
﹤0.01% 2024
2024
Q3
$23K Hold
1,799
﹤0.01% 2085
2024
Q2
$15K Hold
1,799
﹤0.01% 2255
2024
Q1
$19K Sell
1,799
-2,856
-61% -$31.7K ﹤0.01% 2160
2023
Q4
$48K Sell
4,655
-536
-10% -$4.27K ﹤0.01% 2274
2023
Q3
$33K Hold
5,191
﹤0.01% 2435
2023
Q2
$45K Buy
+5,191
New +$46.5K ﹤0.01% 2371

Other funds holding ZYME

Amalgamated Bank's ZYME Position: Q1 2026 in Review

Amalgamated Bank sold out of Zymeworks (ZYME) in Q1 2026, closing a stake of 1,566 shares — an estimated $41K sold.

Amalgamated Bank first reported a position in ZYME in Q2 2023 and held it in 11 quarters. The position peaked at $48K in Q4 2023. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Amalgamated Bank reported no remaining Zymeworks position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 1,566 Zymeworks shares in Q1 2026, an estimated $41K.
  • Amalgamated Bank first reported a position in Zymeworks in Q2 2023 and held it in 11 quarters.
  • Amalgamated Bank's Zymeworks position peaked at $48K in Q4 2023.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.